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Abstract
Background: Akathisia is an inner urge to move a body area with an objective motor component of restlessness. Tardive akathisia (TA) is usually bilateral with a
predominant lower-body presentation. We report two patients with an asymmetrical predominantly upper-body involvement.
Case Report: Two young men with history of psychiatric problems and neuroleptic use revealed atypical TA, characterized by asymmetrical and predominantly
upper-body involvement. Their main manifestations were rubbing the face, mostly with one hand, accompanied by an inner sensation of restlessness.
Discussion: Our patients are proof that TA can present with asymmetrical and upper-body involvement even with normal brain imaging.
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Introduction
Akathisia, defined as a sense of inner unease and urge to move
a body area accompanied by an objective motor component of
restlessness, may be seen in the setting of a number of disorders such as
Parkinson’s disease and brain injuries but is more commonly a drug-
induced phenomenon, mostly related to dopamine receptor blockers,
such as neuroleptics.1 Acute, persistent, and tardive akathisia (TA)
and pseudoakathisia may follow neuroleptic intake although this
classification is not globally accepted. TA, one of the most common
neuroleptic-induced tardive syndromes, is also one of the most
disabling.
TA syndromes described to date are usually bilateral with pre-
dominant lower-body involvement including repeated knee crossing,
plantar and dorsiflexion of the toes and feet, changing the body
position when sitting, walking on the spot, and body swaying, which
vary in severity.1
Herein we present two patients considered to have atypical TA due to
their asymmetrical and markedly predominant upper-body involvement.
Case reports
Case 1
A 44-year-old male with a 3-year history of bipolar mood disorder
was admitted to a specialized psychiatric center 2 years earlier because
of an episode of mania and psychosis. Unfortunately, we do not have
full access to the patient’s medical records, but he was discharged on
fluvoxamine 100 mg twice a day (BD) and haloperidol decanoate 50
mg intramuscular injection (IM) monthly. During the past year he had
developed abnormal movements characterized by repeated jaw
opening and tongue thrusting. He was also continuously rubbing his
forehead, both eyes, and the perioral area with his left hand
accompanied by unceasing flexion and extension movements in the
neck. He reported a general inner feeling of restlessness Video 1.
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During the past year, haloperidol was stopped, and he was started
on tetrabenazine 25 mg three times a day, trihexyphenidyl 2 mg three
times a day, and clonazepam 1 mg every night at bedtime (QHS) in an
attempt to control his abnormal movements but with poor results.
Except for the abnormal movements, his neurological examination
was unremarkable. Table 1 shows his scores on the Barnes Akathisia
Rating Scale (BARS).2 There were no trophic changes in his upper
extremities, and deep tendon reflexes, strength, and coordination were
normal. In addition to the abnormal movements described above,
he had parkinsonian features in the form of axial and appendicular
rigidity and mild hypokinesia. He had no tremor. Brain magnetic
resonance imaging (MRI) and electroencephalography were within
normal limits.
He was diagnosed with TA plus tardive dyskinesia and drug-indu-
ced Parkinsonism. Trihexyphenidyl and tetrabenazine were tapered
and eventually discontinued, and the clonazepam dose was increased
to 2 mg two times a day. Clozapine was also added, up to 150 mg.
Symptoms improved markedly but did not completely disappear.
Later, lamotrigine 100 mg BD and gabapentin 300 mg three times a
day (TDS) were added in an attempt to achieve full recovery Video 2.
Case 2
A 30-year-old male was referred to our unit by his psychiatrist with a
diagnosis of generalized anxiety disorder (GAD) and panic attacks for
the past year. Symptoms were only partially responsive to the usual
anti-anxiety medications and he was eventually started on trifluoper-
azine 3 mg per day. After 3 months of therapy, his psychiatric symp-
toms resolved but he developed an abnormal movement characterized
by excessive rubbing of his eyes and the periorbital and frontal areas
using both hands, with a marked predominance of the left hand
associated with a sensation of facial tingling and an urge to move his
left upper extremity Video 3.
In addition to trifluoperazine, he was taking clonazepam 1 mg
QHS. There were no personal or family histories of abnormal move-
ments, and he denied any substance abuse.
On examination, the patient clearly seemed restless and was con-
stantly touching and rubbing the skin over his forehead and the
periorbital area with his left hand. He also displayed repetitive forward
flexion of the trunk, excessive blinking, and minor dyskinetic move-
ments of the neck. Table 1 summarizes the severity of his symptoms
using the BARS scale. His general and neurologic examination—other









Right Left Right Left Right Left Right Left
Patient 1 0 2 1 3 0 3 0 5
Patient 2 1 2 1 3 1 3 1 5
Video 1. Case 1. Akathisia characterized by ceaseless rubbing of the eyes,
periorbital, and forehead areas with upper extremity and repetitive side-to-side
swaying of the head. Dyskinetic movements characterized by abnormal jaw
opening and blepharospasm are also seen.
Video 2. Case 1. This video shows the first case in another visit. Jaw and eye
dystonia are much less because of botulinum toxin injections. This video shows
that the trunk and lower limbs are grossly not involved.
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than the involuntary movements—were intact. He had normal brain
MRI and routine laboratory examinations.
The diagnosis of TA accompanied by mild blepharospasm was
established and an attempt to ameliorate symptoms by stopping
trifluoperazine and increasing clonazepam to 1 mg BD was trialed.
The symptoms improved but did not disappear completely. Panic
attacks and GAD symptoms recurred, and he reported excessive
daytime sleepiness. He was then started on clozapine 25 mg a day
while clonazepam was discontinued, with striking satisfactory results.
Discussion
The term akathisia has a Greek background meaning ‘‘not to sit’’.
It was first described in 1902 in hysteric and neurotic patients and later
in 1923 in idiopathic Parkinson disease and post-encephalitic Par-
kinsonism. It was not until 1947 that akathisia was reported as an
extrapyramidal complication of neuroleptic drugs.3
There is no definite diagnostic criteria for akathisia, but in its typical
presentation it usually consists of two components.3 The subjective
aspect of akathisia implies feelings of inner restlessness and mental
unease, distress, and having a particular sense of tension, pain, or even
paresthesia in the limbs. The objective component is defined by
restlessness, in the form of complex, repetitive, and seemingly
purposeful movements of the limbs, the most characteristic of them
being rocking from foot to foot or pacing on the spot while standing.
Akathisia is the most common neuroleptic-induced movement
disorder.2 Drug-induced akathisia is classified into acute, persistent,
tardive, and pseudoakathisic forms. The acute form occurs within days
of starting the medication, and tends to subside on dose reduction or
especially discontinuation of the responsible drug.3 If it does not
disappear on drug discontinuation and requires specific therapy, it is
called persistent akathisia. TA usually develops with a latency of
months to years of chronic medication use. The definition of a tardive
syndrome requires a minimum of 6 weeks of drug intake, but it has also
been reported with shorter periods. In pseudoakathisia, the complex
and repetitive movements are present but the patient seems unaware
of the urge to move. In other words the subjective component of
akathisia is absent.4
Although akathisia has been described in frontal lobe injury5 and
subthalamic nucleus (STN) abscess,6 its central pathways have not
been anatomically localized so far. The ultimate responsible bio-
chemical mechanism of akathisia has still to be identified. It has been
proposed that patients with defective iron metabolism are probably
more prone to develop neuroleptic-induced akathisia.7
As akathisia is a very common side effect of dopamine blockers and
dopamine depletor agents, dopaminergic pathways have also been
proposed as a possible pathophysiologic mechanism. This could
explain why both akathisia and Parkinsonism may occur as a com-
plication of the dopamine blocker or dopa depletory medications.
Interestingly the two pathophysiologic etiologies explained above are
related. It has been shown that iron distribution in the human brain
follows the distribution of dopaminergic neurons, and D2 receptor
density is decreased in iron-deficient animal models.8
Different reviews have estimated the incidence of drug-induced
akathisia as between 20% and 75%3 and depends on the type of the
offending drug, dose and duration of drug intake, and probably genetic
backgrounds. Akathisia is most commonly seen as a complication of
typical and atypical neuroleptics, but it also occurs following anti-
emetics, dopamine depletors, and antidepressant medications including
Tricyclic antidepressants (TCAs), selective serotonin reuptake inhibi-
tors (SSRIs), and mono amino oxidase inhibitors (MAOIs).
The clinical features of neuroleptic-induced akathisia are virtually
always bilateral and more often with lower-body involvement.9 In the
present article we present two TA patients with a unilateral and
predominant upper-body involvement. There are sparse reports of
unilateral akathisia. Carrazana et al.6 reported unilateral akathisia in a
patient with acquired immune deficiency syndrome and subthalamic
toxoplasmosis abscess. Hermesch and Monitz10 reported four patients
with unilateral neuroleptic-induced akathisia. They mentioned that both
the subjective and the objective components of akathisia in these patients
had a unilateral predominance. But the neuroleptic-induced akathisia in
all those patients was acute and, in addition, only two of these four
patients had normal brain computed tomography scans. They hypo-
thesized that the ‘‘akathisia area’’ is different in the two hemispheres.
Neuroleptic-induced akathisia is not actually a benign condition. It
causes major distress to the patient, may result in aggressive and
suicidal behavior, and impairs adhesion to treatment in psychiatric
diseases. This highlights the importance of diagnosing and treating
akathisia, which despite its high incidence is commonly under-
diagnosed or misdiagnosed as agitated depression or neurosis. The
atypical presentations of akathisia are much more prone to be over-
looked by specialists, which motivated us in reporting our experience
here. Additional evaluation of these patients such as functional MRI
could probably lead us toward the anatomical localization of akathisia
and its pathophysiology.
Video 3. Case 2. Akathisia characterized by non-stop rubbing of the eyes and
face with the upper extremities with a significant left predominance.
Blepharospasm and neck dystonia are also noted.
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